[ad_1]
“Regarding AstraZeneca, I would like to say that the vaccine is safe, otherwise it would not be registered in the European Union. The fact that a specific batch for which information was received was removed from vaccination will be decided for that particular batch and we will decide when we will receive information on that particular batch, ”I. Šimonytė said at a press conference held in the Government on Wednesday. .
ELTA recalls that the State Medicines Agency, after receiving information from the Austrian competent authority, has recommended the temporary suspension of the use of the AstraZeneca ABV5300 series vaccine.
The Austrian Federal Health Service (BASG) has received two notifications, possibly related to the vaccination of the same batch of AstraZeneca vaccine. A study is currently underway to investigate two suspected adverse reactions in Austria: thrombosis and pulmonary embolism.
SAM and international experts emphasize that there are no objective reasons to worry or worry. Based on data from clinical trials, thromboembolism is not a typical side effect of AstraZeneca. The international analysis initiated of reports of side effects also does not show similar cases in the past. In order to ensure public safety and clear up doubts, the goal is to verify any assumptions about the safety of vaccines.
No part of this publication may be reproduced without the written permission of ELTA.
[ad_2]
